Your browser is no longer supported. Please, upgrade your browser.
Hercules Capital, Inc.
Index- P/E6.12 EPS (ttm)2.80 Insider Own1.26% Shs Outstand115.74M Perf Week-1.89%
Market Cap1.98B Forward P/E12.15 EPS next Y1.41 Insider Trans-7.26% Shs Float113.09M Perf Month1.06%
Income- PEG1.22 EPS next Q0.32 Inst Own30.32% Short Float1.71% Perf Quarter8.72%
Sales282.40M P/S7.02 EPS this Y-6.50% Inst Trans- Short Ratio2.84 Perf Half Y20.89%
Book/sh11.48 P/B1.49 EPS next Y8.50% ROA- Target Price18.35 Perf Year62.10%
Cash/sh- P/C- EPS next 5Y5.00% ROE- 52W Range9.78 - 17.65 Perf YTD19.64%
Dividend1.28 P/FCF- EPS past 5Y5.37% ROI- 52W High-2.94% Beta-
Dividend %7.47% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low75.08% ATR0.26
Employees82 Current Ratio- Sales Q/Q-6.60% Oper. Margin- RSI (14)48.94 Volatility1.40% 1.19%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.98 Prev Close17.30
ShortableYes LT Debt/Eq- EarningsApr 29 AMC Payout- Avg Volume681.12K Price17.13
Recom1.50 SMA20-0.13% SMA500.20% SMA20017.90% Volume666,470 Change-0.98%
Apr-28-21Initiated Oppenheimer Outperform $17.50
Mar-25-21Initiated RBC Capital Mkts Outperform $17
Nov-02-20Resumed JMP Securities Mkt Outperform $13
Jul-31-20Upgrade Compass Point Neutral → Buy $12.75
Jul-20-20Resumed Piper Sandler Overweight $12
Jun-19-20Upgrade Janney Neutral → Buy
Mar-31-20Upgrade Keefe Bruyette Mkt Perform → Outperform
Nov-04-19Upgrade Wells Fargo Market Perform → Outperform
May-06-19Downgrade Wells Fargo Outperform → Market Perform $12.75 → $13.25
May-03-19Upgrade B. Riley FBR Neutral → Buy $11.50 → $15
Mar-13-19Downgrade Keefe Bruyette Outperform → Mkt Perform $14 → $11.50
Mar-13-19Downgrade B. Riley FBR Buy → Neutral $15 → $11.50
Feb-07-18Upgrade Wedbush Neutral → Outperform $13.75
Feb-06-18Upgrade Sandler O'Neill Hold → Buy
Nov-20-17Initiated Ladenburg Thalmann Buy
Nov-03-17Upgrade Raymond James Underperform → Mkt Perform
Oct-25-17Initiated Wedbush Neutral $13.25
Oct-02-17Resumed FBR & Co. Buy $14
Sep-08-17Upgrade Compass Point Neutral → Buy
Aug-07-17Resumed JMP Securities Mkt Outperform $14.50
Jun-08-21 06:00AM  
Jun-04-21 08:05AM  
Jun-03-21 07:01AM  
May-28-21 01:05PM  
May-26-21 08:50PM  
May-21-21 07:11AM  
May-19-21 08:00AM  
May-14-21 08:30AM  
May-13-21 04:03PM  
May-12-21 10:35AM  
Apr-30-21 08:04AM  
Apr-29-21 04:10PM  
Apr-27-21 06:03AM  
Apr-22-21 12:33PM  
Apr-15-21 06:00AM  
Mar-25-21 11:30AM  
Mar-08-21 09:13AM  
Mar-05-21 01:22PM  
Mar-04-21 04:21PM  
Mar-02-21 06:00AM  
Feb-25-21 11:29PM  
Feb-24-21 08:11AM  
Feb-23-21 10:31PM  
Feb-22-21 06:02AM  
Feb-11-21 01:11PM  
Feb-09-21 11:12AM  
Feb-08-21 06:09AM  
Feb-01-21 11:13AM  
Jan-19-21 10:00AM  
Dec-13-20 11:08PM  
Nov-25-20 08:22AM  
Nov-18-20 10:00AM  
Nov-04-20 05:03PM  
Nov-03-20 11:57AM  
Oct-30-20 12:13PM  
Oct-29-20 07:15PM  
Oct-28-20 04:10PM  
Oct-27-20 06:02AM  
Oct-22-20 06:00AM  
Oct-01-20 04:30PM  
Sep-29-20 07:00AM  
Sep-01-20 11:29AM  
Aug-29-20 11:31AM  
Aug-04-20 09:55AM  
Jul-31-20 11:25AM  
Jul-30-20 05:25PM  
Jul-29-20 06:00AM  
Jul-24-20 12:10PM  
Jul-23-20 12:32PM  
Jul-22-20 04:10PM  
Jul-02-20 09:44AM  
Jun-27-20 09:55PM  
Jun-09-20 10:42AM  
Jun-08-20 06:00AM  
Jun-03-20 04:10PM  
Jun-01-20 04:01PM  
May-22-20 06:12PM  
May-05-20 12:23PM  
May-04-20 06:35PM  
May-01-20 06:00AM  
Apr-27-20 12:32PM  
Apr-24-20 09:30AM  
Apr-17-20 10:17AM  
Apr-16-20 06:00AM  
Apr-03-20 09:43AM  
Mar-23-20 06:00AM  
Mar-21-20 11:30AM  
Mar-20-20 06:55AM  
Mar-03-20 04:05PM  
Feb-28-20 12:55PM  
Feb-27-20 05:30PM  
Feb-21-20 09:37AM  
Feb-20-20 04:10PM  
Feb-19-20 04:12PM  
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in Connecticut; Boston, Massachusetts; Elmhurst, Illinois; Santa Monica, California; McLean, Virginia; New York, New York; Radnor, Pennsylvania; and Washington, District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BADAVAS ROBERT PDirectorMay 04Sale17.5020,000350,000107,452May 05 04:16 PM
Fallon Thomas JDirectorMay 03Option Exercise16.3410,000163,40059,937May 03 04:51 PM
CROWELL GAYLE ADirectorMay 03Buy17.503776,59814,109May 03 04:51 PM
Bluestein ScottChief Executive OfficerMar 18Sale15.8080,0001,264,000923,086Mar 19 05:10 PM
Fallon Thomas JDirectorMar 15Option Exercise11.4415,000171,60064,937Mar 16 04:23 PM
Fallon Thomas JDirectorMar 15Sale16.5615,000248,40049,937Mar 16 04:23 PM
BADAVAS ROBERT PDirectorMar 01Option Exercise10.605,00053,000127,452Mar 03 05:42 PM
Hoffman Joseph FDirectorMar 01Option Exercise12.4715,000187,05052,124Mar 03 05:41 PM
Ho Doreen WooDirectorMar 01Option Exercise13.6110,000136,10031,569Mar 03 05:40 PM
Foster Carol LDirectorNov 18Buy12.993,85050,01216,551Nov 18 05:08 PM